Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody

Nuclear Medicine and Biology

Volumn 39, Issue 1, 2012, Pages 137-144

  Chen, Delphine L ^a   Zhou, Dong ^a   Chu, Wenhua ^a   Herrbrich, Phillip ^a   Engle, Jacquelyn T ^a   Griffin, Elizabeth ^a   Jones, Lynne A ^a   Rothfuss, Justin M ^a   Geraci, Marco ^b   Hotchkiss, Richard S ^c   Mach, Robert H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FAS ANTIBODY; ISATIN DERIVATIVE; MEBROFENIN TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; WC 98 C 11; WC II 89 F 18; WC IV 3 F 18;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG PROTEIN BINDING; DRUG RETENTION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HEPATOBILIARY SYSTEM; ISOTOPE LABELING; LIVER; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; POSITRON EMISSION TOMOGRAPHY;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CARBON RADIOISOTOPES; CASPASE 3; ENZYME ACTIVATION; FEMALE; FLUORINE RADIOISOTOPES; ISATIN; LIVER; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; QUINOLINES; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION;

EID: 84855337777     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.08.001     Document Type: Article

References (25)

1. Yagle K.J., Eary J.F., Tait J.F., Grierson J.R., Link J.M., Lewellen B., et al. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 2005, 46(4):658-666.
2. Madar I., Ravert H., Nelkin B., Abro M., Pomper M., Dannals R., et al. Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation. Eur J Nucl Med Mol Imaging 2007, 34(12):2057-2065.
3. Madar I., Ravert H.T., Du Y., Hilton J., Volokh L., Dannals R.F., et al. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med 2006, 47(8):1359-1366.
4. Reshef A., Shirvan A., Waterhouse R.N., Grimberg H., Levin G., Cohen A., et al. Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J Nucl Med 2008, 49(9):1520-1528.
5. Cohen A., Shirvan A., Levin G., Grimberg H., Reshef A., Ziv I. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res 2009.
6. Reed J.C. Apoptosis mechanisms: implications for cancer drug discovery. Oncology (Williston Park) 2004, 18(13 Suppl 10):11-20.
7. Green D.R. Apoptotic pathways: ten minutes to dead. Cell 2005, 121(5):671-674.
8. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science 1998, 281(5381):1312-1316.
9. Broker L.E., Kruyt F.A., Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 2005, 11(9):3155-3162.
10. Kitanaka C., Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 1999, 6(6):508-515.
11. Salvesen G.S., Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell 1997, 91(4):443-446.
12. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996, 93(6):2239-2244.
13. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007, 35(4):495-516.
14. Chapman J.G., Magee W.P., Stukenbrok H.A., Beckius G.E., Milici A.J., Tracey W.R. A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury. Eur J Pharmacol 2002, 456(1-3):59-68.
15. Lee D., Long S.A., Adams J.L., Chan G., Vaidya K.S., Francis T.A., et al. Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem 2000, 275(21):16007-16014.
16. Chen D.L., Zhou D., Chu W., Herrbrich P.E., Jones L.A., Rothfuss J.M., et al. Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography. Nucl Med Biol 2009, 36(6):651-658.
17. Zhou D., Chu W., Rothfuss J., Zeng C., Xu J., Jones L., et al. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. Bioorg Med Chem Lett 2006, 16(19):5041-5046.
18. Faust A., Wagner S., Law M.P., Hermann S., Schnockel U., Keul P., et al. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)s ulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. Q J Nucl Med Mol Imaging 2007, 51(1):67-73.
19. Nguyen Q.D., Smith G., Glaser M., Perumal M., Arstad E., Aboagye E.O. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Proc Natl Acad Sci USA 2009, 106(38):16375-16380.
20. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993, 364(6440):806-809.
21. Blankenberg F.G., Katsikis P.D., Tait J.F., Davis R.E., Naumovski L., Ohtsuki K., et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998, 95(11):6349-6354.
22. Ghibellini G., Leslie E.M., Pollack G.M., Brouwer K.L. Use of Tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies. Pharm Res 2008, 25(8):1851-1860.
23. Zhou D., Chu W., Chen D.L., Wang Q., Reichert D.E., Rothfuss J., et al. [18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98. Org Biomol Chem 2009, 7(7):1337-1348.
24. Ogura Y., Krams S.M., Martinez O.M., Kopiwoda S., Higgins J.P., Esquivel C.O., et al. Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology 2000, 214(3):795-800.
25. Leithauser F., Dhein J., Mechtersheimer G., Koretz K., Bruderlein S., Henne C., et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993, 69(4):415-429.